EDC software comparison:
Clinion vs the leading EDC platforms in 2026
Choosing the right Electronic Data Capture (EDC) system involves much more than comparing eCRFs and edit checks. This guide compares Clinion EDC with Medidata Rave, Veeva Vault, Medrio, Viedoc, Castor, OpenClinica, TrialKit, and ClinCapture across key areas including study build, AI capabilities, data review, integrations, usability, and cost, helping you identify the EDC platform that best aligns with your organization’s clinical trial needs.
— In brief
Which EDC software should clinical trial teams evaluate?
There is no single Electronic Data Capture (EDC) platform that is best for every trial. The right platform depends on your organization, study phase, therapeutic area, operational complexity, integration requirements and the level of automation or AI you expect from your clinical technology stack.
Large global sponsors may place greater emphasis on enterprise scalability and established infrastructure, making platforms such as Medidata Rave and Veeva Vault as common options to evaluate. Emerging and mid-size CROs, biotech, and medical device organizations may place greater emphasis on rapid study-build, ease of use, integrated eClinical capabilities, flexible deployment and cost predictability. Platforms such as Clinion, Medrio, Viedoc, Castor, TrialKit, and ClinCapture are among the cloud-based EDC solutions that may be considered for these requirements. OpenClinica adds a modular option with open-source heritage. The sections below compare these EDC systems using a consistent framework so teams can narrow the list for further evaluation.
— The framework
What is EDC software, and what should you compare in 2026?
Electronic Data Capture (EDC) software is used to collect, manage, review and export clinical trial data through electronic case report forms (eCRFs). For regulated studies, teams typically assess or evaluate 21 CFR Part 11, EU Annex 11, GCP, privacy, validation, security and data standards based on study geography and risk. In 2026, many EDC platforms also connect with broader clinical data management and eClinical workflows leading teams to increasingly compare the complete operating model rather than data capture alone.
Before comparing EDC vendors, it helps to define the criteria that matters most for your study and operating model. Most teams evaluate the same core dimensions:
Study build and configuration:
Protocol-to-production speed, whether programming is required, reusable CDASH libraries, and edit-check setup.
Mid-study changes:
Whether visits, forms, fields, and logic can be updated after go-live, and whether that needs downtime or vendor involvement.
Clinical data review:
Query management, discrepancy detection, SDV and remote SDV, centralised and audit-trail review, and medical coding.
Reporting and analytics:
Whether users can build and schedule their own reports without programming, and access data in real time.
AI and automation:
Not whether a vendor ‘has AI,’ but what the AI actually does across setup, coding, extraction, review, and reporting by adding value.
Connected eClinical modules:
Whether EDC links natively with RTSM, ePRO/eCOA, eConsent, eSource, CTMS, and eTMF.
Regulatory, security, and standards:
Validation, audit trail, data standards, and the geographies your studies require.
— The landscape
How is the EDC market structured in 2026?
The market splits into a small group of enterprise vendors serving big pharma, and a fast-growing tier of cloud-native platforms serving emerging and mid-size sponsors, CROs, biotech, and medical device teams. Across both segments, three themes are shaping evaluation criteria: unified eClinical ecosystems, decentralised and hybrid trials, and AI-assisted clinical data workflows.
On the enterprise side, Medidata Rave (a Dassault Systemes brand) and Veeva Vault EDC dominate large global programmes with deep submission histories and broad integrations. Notably, Medidata now also offers Rave Lite, a right-sized, faster-deploy version for Phase I, Phase IV, and medical device studies, a direct move into the mid-market. In the cloud tier, Clinion, Medrio, Viedoc, Castor, ClinCapture, and TrialKit compete on study-builder simplicity, speed, unified modules, and predictable pricing. OpenClinica pairs an open-source community edition with a commercial platform. The clearest recent shift is AI: a subset of vendors now build machine learning and generative AI into the platform rather than treating it as a separate analytics add-on.
The nine EDC platforms at a glance
A high-level orientation before the detailed EDC software comparison. Most platforms here describe cloud-based deployments and features designed to support regulated clinical research. Confirm validation, 21 CFR Part 11, EU Annex 11, security, and regional requirements directly with each vendor during due diligence.
| Platform | Key differentiator | Typical fit | Study build | Pricing model |
|---|---|---|---|---|
| Clinion EDC | Cloud-native, Enterprise-grade eClinical capabilities without enterprise complexity—AI-powered, integrated and built for rapid study deployment | Emerging & mid-size CROs, biotech, MedTech, pharma | Accelerated — standardized Global Library; 4-week average go-live | Study-scoped (quote) |
| Medidata Rave | Enterprise scale & submission history | Large pharma, global Phase III (+ Rave Lite for smaller studies) | AI-assisted; Rave Lite for smaller studies | Enterprise contract |
| Veeva Vault EDC | Veeva Vault suite integration | Veeva-native organisations | Configurable; reports speed gains | Enterprise contract |
| Medrio EDC | No-code, strong support | Small & scaling clinical teams | Fast | Per-study |
| Viedoc | Usability, self-service | CROs, sponsors, academia (global) | Fast | Model published; quote |
| Castor | Unified suite, MDR/PMCF, DCT | MedTech, academic, biopharma | Fast | Personalised / tailored |
| OpenClinica | Commercial platform + community edition | Sponsors, CROs, sites, academia | Managed builds in days | Free + paid enterprise |
| TrialKit | Mobile-first; Floyd build & live-data AI | CROs & sponsors wanting mobile | Fast | Contact vendor |
| ClinCapture | No-code setup, Remote-trial support | Growing CROs, remote trials | Fast | By quote |
- Differentiator
- Cloud-native, Enterprise-grade eClinical capabilities without enterprise complexity—AI-powered, integrated and built for rapid study deployment
- Typical fit
- Emerging & mid-size CROs, biotech, MedTech, pharma
- Study build
- Accelerated — standardized Global Library; 4-week average go-live
- Pricing
- Study-scoped (quote)
- Differentiator
- Enterprise scale & submission history
- Typical fit
- Large pharma, global Phase III (+ Rave Lite for smaller studies)
- Study build
- AI-assisted; Rave Lite for smaller studies
- Pricing
- Enterprise contract
- Differentiator
- Veeva Vault suite integration
- Typical fit
- Veeva-native organisations
- Study build
- Configurable; reports speed gains
- Pricing
- Enterprise contract
- Differentiator
- No-code, strong support
- Typical fit
- Small & scaling clinical teams
- Study build
- Fast
- Pricing
- Per-study
- Differentiator
- Usability, self-service
- Typical fit
- CROs, sponsors, academia (global)
- Study build
- Fast
- Pricing
- Model published; quote
- Differentiator
- Unified suite, MDR/PMCF, DCT
- Typical fit
- MedTech, academic, biopharma
- Study build
- Fast
- Pricing
- Personalised / tailored
- Differentiator
- Commercial platform + community edition
- Typical fit
- Sponsors, CROs, sites, academia
- Study build
- Managed builds in days
- Pricing
- Free + paid enterprise
- Differentiator
- Mobile-first; Floyd build & live-data AI
- Typical fit
- CROs & sponsors wanting mobile
- Study build
- Fast
- Pricing
- Contact vendor
- Differentiator
- No-code setup, Remote-trial support
- Typical fit
- Growing CROs, remote trials
- Study build
- Fast
- Pricing
- By quote
— Platform profiles
Clinical trial EDC software: platform-by-platform comparison
A fair profile of each platform: an overview, real strengths, honest considerations, and who it suits.
For a deep, one-to-one comparison, follow the link on each card.
Clinion EDCCloud-native, AI-native
AI-powered capabilities seamlessly integrated across a unified eClinical platform encompassing EDC, eConsent, RTSM, CTMS, ePRO, eSource and eTMF to streamline clinical trial operations, enhance data quality, and improve operational efficiency.
Strengths
Clinion brings AI-assisted workflows into study build, CDASH mapping, source-to-CRF, medical coding, a DICOM image repository with automatic PHI de-identification, audit-trail review with Ask ATR AI, agentic data review, reporting and query workflows, and remote SDV plus Agentic Assistant for conversational protocol, study operations, and clinical-data querying, with human-in-the-loop review and oversight. Clinion supports codeless study build configuration through a CDASH-aligned Global Library, real-time mid-study changes without downtime, and study-scoped pricing.
Considerations
Compare how Clinion’s AI-assisted capabilities align with your validation, human-in-the-loop review, and change-control processes. Its published third-party review base is smaller than Viedoc’s or Castor’s. Clinion has also supported studies submitted to the FDA and other regulators, though its overall submission track record is newer than Medidata’s or Veeva’s.
Common fit
Emerging and mid-size CROs, biotech, MedTech, and pharma that want AI-assisted clinical data workflows and a connected platform.
Medidata Rave EDCEnterprise
Enterprise EDC from Medidata, a Dassault Systemes company, designed for complex global clinical trials.
Strengths
A broad enterprise integrated ecosystem, Rave RTSM, Patient Cloud eCOA, AI-assisted configuration via Medidata Designer, and analytics through Clinical Data Studio. Rave Lite provides an option positioned for early phase, Phase IV, and medical device studies.
Considerations
Assess the implementation model, configuration resources, ecosystem dependencies and total cost of ownership for your portfolio. Smaller teams should also compare high total cost of ownership and whether the full enterprise breadth is necessary for their study complexity.
Common fit
Large pharma and global CROs running complex, multi-region studies, and, via Rave Lite, teams wanting Rave technology for simpler trials.
Veeva Vault EDCEnterprise
Part of the Veeva Vault Clinical Suite, suited to organizations standardizing on the Veeva platform.
Strengths
Tight integration with other Vault applications (eTMF, CTMS, eConsent), modern cloud architecture, agile study design for complex builds, targeted SDV, and no-downtime amendments. A productized EDC-to-RTSM connection can synchronize defined subject data automatically.
Considerations
Veeva Vault EDC is most compelling to evaluate for organisations already using or considering the broader Vault Clinical Suite. Assess standalone requirements, integration scope, pricing, and the level of built-in AI available for your use cases.
Common fit
Biopharma and pharma already invested in, or moving to, the Veeva platform.
Medrio EDCCloud SaaS
Cloud-based EDC for small and scaling clinical teams.
Strengths
A no-code builder, reusable study components, an always-on validation environment, near-real-time data access, offline data capture, and user-controlled mid-study changes. Strong customer-support reputation with 24/7 availability, and a wider suite spanning ePRO, eConsent, RTSM, CTMS, and eTMF. Rated well on ease of use and value.
Considerations
Evaluate fit for complex global programmes, advanced AI requirements, regional support needs, and the level of vendor involvement required for your operating model.
Common fit
US clinical-stage biotech, MedTech, and small-to-mid teams running straightforward protocols.
ViedocCloud SaaS
Scandinavian-origin cloud EDC known for usability.
Strengths
Drag-and-drop design for eCRFs, workflows, and edit checks, real-time validation, rapid mid-study changes, REST API connectivity, CDISC-compatible formats, and strong study-team self-sufficiency. Consistently high usability ratings and a large third-party review base, plus published tiered pricing.
Considerations
More limited AI-assisted capabilities, a smaller submission library than the enterprise vendors, internet dependence with limited offline support, and maturing support for the most complex studies.
Common fit
CROs, academic sites, and mid-size sponsors that prioritize user experience, especially in Europe.
Castor EDCCloud-native SaaS
Cloud-native platform combining EDC, eCOA, eConsent, and RWE.
Strengths
A no-code study builder, connected EDC, eCOA, and eConsent, personalized and tailored pricing, specific MDR/PMCF and decentralized-trial support, Catalyst source-data extraction with human confirmation, and a large global user base across academic and biopharma research.
Considerations
More limited AI across the lifecycle than AI-assisted platforms, a smaller submission history than Medidata or Veeva, and limited offline access. Check which capabilities are native to core EDC versus adjacent products.
Common fit
Medical device, academic, and biopharma teams running Phase I to IV, DCT, and RWE studies.
OpenClinicaOpen-source / Enterprise
Open-source heritage EDC with a modular commercial platform.
Strengths
A freely available community edition alongside a commercial platform with drag-and-drop and managed study build, real-time validation, query management, SDV, eCOA, eConsent, randomization, EHR-to-EDC connectivity, coding, and analytics. Active user community.
Considerations
Teams using community or self-managed deployments should account for internal technical resources and maintenance. For commercial evaluations, compare current OpenClinica capabilities rather than assumptions based on earlier open-source versions, and confirm the scope of available AI-assisted functionality.
Common fit
Sponsors, CROs, sites, and academic institutions seeking flexible, modular clinical research technology.
TrialKitCloud SaaS
Unified, mobile-first eClinical platform by Crucial Data Solutions.
Strengths
A comprehensive module set (EDC, eSource, eCOA/ePRO, eConsent, eTMF, RTSM, coding), mobile apps across devices, flexibility during amendments, embedded intelligence for study design, validation, and analysis, and flexible subscriptions. Suited to conventional, hybrid, and decentralised studies.
Considerations
For smaller or simpler studies, cloud-dependent, with a configuration learning curve. Confirm the depth of its AI functions and support model for your portfolio.
Common fit
CROs and sponsors that want a mobile-friendly, comprehensive unified platform.
ClinCaptureCloud SaaS
Unified eClinical platform (Captivate) with a no-code builder.
Strengths
Drag-and-drop forms and rules without programming, connected eSource, eCOA/ePRO, eConsent, and RTSM, virtual data capture for remote trials, and AI-assisted study setup (Captivate AI) covering protocol digitization and natural-language configuration with human-in-the-loop review. Full support including 24/7 and chat, and very high user ratings.
Considerations
Higher, flatter published pricing, a smaller review base, and some reported integration limitations. Confirm which capabilities belong to core EDC versus additional Captivate modules.
Common fit
Growing CROs and multi-sponsor organizations running remote and hybrid trials.
AI-powered capabilities seamlessly integrated across a unified eClinical platform encompassing EDC, eConsent, RTSM, CTMS, ePRO, eSource and eTMF to streamline clinical trial operations, enhance data quality, and improve operational efficiency.
Clinion brings AI-assisted workflows into study build, CDASH mapping, source-to-CRF, medical coding, a DICOM image repository with automatic PHI de-identification, audit-trail review with Ask ATR AI, agentic data review, reporting and query workflows, and remote SDV plus Agentic Assistant for conversational protocol, study operations, and clinical-data querying, with human-in-the-loop review and oversight. Clinion supports codeless study build configuration through a CDASH-aligned Global Library, real-time mid-study changes without downtime, and study-scoped pricing.
Compare how Clinion’s AI-assisted capabilities align with your validation, human-in-the-loop review, and change-control processes. Its published third-party review base is smaller than Viedoc's or Castor's. Clinion has also supported studies submitted to the FDA and other regulators, though its overall submission track record is newer than Medidata's or Veeva's.
Emerging and mid-size CROs, biotech, MedTech, and pharma that want AI-assisted clinical data workflows and a connected platform.
Enterprise EDC from Medidata, a Dassault Systemes company, designed for complex global clinical trials.
A broad enterprise integrated ecosystem, Rave RTSM, Patient Cloud eCOA, AI-assisted configuration via Medidata Designer, and analytics through Clinical Data Studio. Rave Lite provides an option positioned for early phase, Phase IV, and medical device studies.
Assess the implementation model, configuration resources, ecosystem dependencies and total cost of ownership for your portfolio. Smaller teams should also compare high total cost of ownership and whether the full enterprise breadth is necessary for their study complexity.
Large pharma and global CROs running complex, multi-region studies, and, via Rave Lite, teams wanting Rave technology for simpler trials.
Full comparison: Clinion vs Medidata →
Part of the Veeva Vault Clinical Suite, suited to organizations standardizing on the Veeva platform.
Tight integration with other Vault applications (eTMF, CTMS, eConsent), modern cloud architecture, agile study design for complex builds, targeted SDV, and no-downtime amendments. A productized EDC-to-RTSM connection can synchronize defined subject data automatically.
Veeva Vault EDC is most compelling to evaluate for organisations already using or considering the broader Vault Clinical Suite. Assess standalone requirements, integration scope, pricing, and the level of built-in AI available for your use cases.
Biopharma and pharma already invested in, or moving to, the Veeva platform.
Full comparison: Clinion vs Veeva →
Cloud-based EDC for small and scaling clinical teams.
A no-code builder, reusable study components, an always-on validation environment, near-real-time data access, offline data capture, and user-controlled mid-study changes. Strong customer-support reputation with 24/7 availability, and a wider suite spanning ePRO, eConsent, RTSM, CTMS, and eTMF. Rated well on ease of use and value.
Evaluate fit for complex global programmes, advanced AI requirements, regional support needs, and the level of vendor involvement required for your operating model.
US clinical-stage biotech, MedTech, and small-to-mid teams running straightforward protocols.
Full comparison: Clinion vs Medrio →
Scandinavian-origin cloud EDC known for usability.
Drag-and-drop design for eCRFs, workflows, and edit checks, real-time validation, rapid mid-study changes, REST API connectivity, CDISC-compatible formats, and strong study-team self-sufficiency. Consistently high usability ratings and a large third-party review base, plus published tiered pricing.
More limited AI-assisted capabilities, a smaller submission library than the enterprise vendors, internet dependence with limited offline support, and maturing support for the most complex studies.
CROs, academic sites, and mid-size sponsors that prioritize user experience, especially in Europe.
Full comparison: Clinion vs Viedoc →
Cloud-native platform combining EDC, eCOA, eConsent, and RWE.
A no-code study builder, connected EDC, eCOA, and eConsent, personalized and tailored pricing, specific MDR/PMCF and decentralized-trial support, Catalyst source-data extraction with human confirmation, and a large global user base across academic and biopharma research.
More limited AI across the lifecycle than AI-assisted platforms, a smaller submission history than Medidata or Veeva, and limited offline access. Check which capabilities are native to core EDC versus adjacent products.
Medical device, academic, and biopharma teams running Phase I to IV, DCT, and RWE studies.
Full comparison: Clinion vs Castor →
Open-source heritage EDC with a modular commercial platform.
A freely available community edition alongside a commercial platform with drag-and-drop and managed study build, real-time validation, query management, SDV, eCOA, eConsent, randomization, EHR-to-EDC connectivity, coding, and analytics. Active user community.
Teams using community or self-managed deployments should account for internal technical resources and maintenance. For commercial evaluations, compare current OpenClinica capabilities rather than assumptions based on earlier open-source versions, and confirm the scope of available AI-assisted functionality.
Sponsors, CROs, sites, and academic institutions seeking flexible, modular clinical research technology.
Full comparison: Clinion vs OpenClinica →
Unified, mobile-first eClinical platform by Crucial Data Solutions.
A comprehensive module set (EDC, eSource, eCOA/ePRO, eConsent, eTMF, RTSM, coding), mobile apps across devices, flexibility during amendments, embedded intelligence for study design, validation, and analysis, and flexible subscriptions. Suited to conventional, hybrid, and decentralised studies.
For smaller or simpler studies, cloud-dependent, with a configuration learning curve. Confirm the depth of its AI functions and support model for your portfolio.
CROs and sponsors that want a mobile-friendly, comprehensive unified platform.
Full comparison: Clinion vs TrialKit →
Unified eClinical platform (Captivate) with a no-code builder.
Drag-and-drop forms and rules without programming, connected eSource, eCOA/ePRO, eConsent, and RTSM, virtual data capture for remote trials, and AI-assisted study setup (Captivate AI) covering protocol digitization and natural-language configuration with human-in-the-loop review. Full support including 24/7 and chat, and very high user ratings.
Higher, flatter published pricing, a smaller review base, and some reported integration limitations. Confirm which capabilities belong to core EDC versus additional Captivate modules.
Growing CROs and multi-sponsor organizations running remote and hybrid trials.
Full comparison: Clinion vs ClinCapture →
How Leading EDC Platforms Compare Across Key Features
A side-by-side view of the capabilities clinical data teams evaluate most. This is a shortlisting aid, not a substitute for a formal RFP or a hands-on trial.
| Capability | Clinion | Medidata Rave | Veeva Vault | Medrio | Viedoc | Castor | OpenClinica | TrialKit | ClinCapture |
|---|---|---|---|---|---|---|---|---|---|
| AI-powered data management | Full lifecycle | Config + analytics | Not emphasised | Partial | Partial | Extraction (Catalyst) | Not emphasised | Yes | Yes |
| In-app AI assistant | Agentic Assistant | – | – | – | – | – | – | Partial | Partial |
| No-code study builder | Yes | Partial | Yes | Yes | Yes | Yes | Partial | Yes | Yes |
| Rapid study build | Global Library | Slow (Rave Lite faster) | Moderate | Fast | Fast | Fast | Moderate | Fast | Fast |
| Mid-study changes, no downtime | Yes | Yes | Yes | Yes | Yes | Yes | Partial | Yes | Yes |
| Native eConsent | Yes | Medidata Consent | Suite | Yes | Yes | Yes | Yes | Yes | Yes |
| Native ePRO / eCOA | Yes | Patient Cloud | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Native RTSM | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Unified eClinical suite | Unified suite | Broad | Vault suite | Moderate | Moderate | Broad | Broad | Broad | Broad |
| DCT / hybrid ready | Yes | Yes | Yes | Yes | Yes | Yes | Partial | Yes | Yes |
| Mobile apps | Web-first | Yes | Partial | Yes | Partial | Partial | Partial | Yes | Yes |
| 21 CFR Part 11 / GCP | Yes + ISO | Yes | Yes | Yes | Yes | Yes + MDR | Yes | Yes | Yes |
| Implementation | Self-serve | Consultant-led | Moderate | Fast | Fast | Fast | Moderate | Fast | Fast |
| Pricing model | Study-based | Enterprise (Rave Lite tailored) | Enterprise | Per-study | Published | Per-study | Free + paid | Subscription | By quote |
| 24/7 support | Yes | SLA | SLA | Yes | Included | Included | Community + paid | Limited | Yes |
Legend: ‘Partial’ or ‘Limited’ means available with restrictions or via integration; ‘Not emphasised’ means not a current public focus; ‘–’ means none noted. Values reflect publicly available product information (vendor sites, G2, Capterra) as of 2026 and are intended for shortlisting only. Capabilities change frequently; verify with each vendor. Clinion’s build, pricing, and module claims are Clinion’s stated figures.
— The 2026 differentiator
How does AI compare across EDC platforms?
Traditional EDC automation relies on configured rules, edit checks, and workflows. Newer platforms add AI to different parts of the data lifecycle, but the use cases are not equivalent. The right question is not whether a vendor has AI, but evaluating the task performed, the data used, the level of human oversight required, validation approach and whether the capabilities are available in production environment.
| Platform | Primary AI / automation focus |
|---|---|
| Clinion | AI study build, CDASH mapping, source-to-CRF, agentic data review, AI reporting and query workflow, remote SDV (rSDV), AI medical coding, DICOM with PHI de-identification, audit-trail review with Ask ATR AI, and the Agentic Assistant, across the clinical data lifecycle with human review |
| Medidata Rave | AI-assisted study configuration (Designer), predictive coding, and data review and oversight (Clinical Data Studio) |
| Veeva Vault | Connected automation across Vault; standalone EDC AI not a current emphasis (verify) |
| Medrio | Data exploration and workflow automation, evolving |
| Viedoc | AI-assisted WHODrug medical coding (Koda) live in production, with human approval; broader AI evolving |
| Castor | AI-assisted source-data extraction and mapping, with human review (Catalyst) |
| OpenClinica | Publicly introduced AI-assisted study-build initiatives (verify current availability); AI concentrated on build |
| TrialKit | Floyd AI: protocol-to-study build, synthetic study simulation and validation, and natural-language analysis of live clinical data |
| ClinCapture | AI-assisted study setup, protocol digitisation, and natural-language configuration (Captivate AI) |
AI study build, CDASH mapping, source-to-CRF, agentic data review, AI reporting and query workflow, remote SDV (rSDV), AI medical coding, DICOM with PHI de-identification, audit-trail review with Ask ATR AI, and the Agentic Assistant, across the clinical data lifecycle with human review
AI-assisted study configuration (Designer), predictive coding, and data review and oversight (Clinical Data Studio)
Connected automation across Vault; standalone EDC AI not a current emphasis (verify)
Data exploration and workflow automation, evolving
AI-assisted WHODrug medical coding (Koda) live in production, with human approval; broader AI evolving
AI-assisted source-data extraction and mapping, with human review (Catalyst)
Publicly introduced AI-assisted study-build initiatives (verify current availability); AI concentrated on build
Floyd AI: protocol-to-study build, synthetic study simulation and validation, and natural-language analysis of live clinical data
AI-assisted study setup, protocol digitisation, and natural-language configuration (Captivate AI)
AI capabilities and terminology change quickly. Confirm current, production AI functionality with each vendor.
How to evaluate an EDC vendor’s AI. Ask each vendor to demonstrate a production workflow, then ask: What task does the AI perform? What inputs does it use? Can users approve or reject its output? Is the recommendation traceable in the audit trail? Does it operate on live clinical data? How is it validated, and what happens when the model is uncertain? Answers to these separate genuine, governed AI from a marketing label.
— Independent evidence
What do third-party user reviews show?
Vendor claims are one input; verified user reviews are another. The table below summarises public ratings from G2 and Capterra. Read them alongside review volume, since a high score from a handful of reviews is not equivalent to a slightly lower score from hundreds.
| Platform | G2 rating | G2 reviews | Capterra rating | Capterra reviews |
|---|---|---|---|---|
| Clinion | 4.6 ★ | 72 | 4.8 ★ | 59 |
| Medidata Rave | 4.7 ★ | 27 | – | – |
| Veeva Vault | 4.1 ★ | 54 | – | – |
| Medrio | 4.2 ★ | 254 | 4.6 ★ | 51 |
| Viedoc | 4.5 ★ | 278 | 4.4 ★ | 95 |
| Castor | 4.6 ★ | 126 | 4.7 ★ | 204 |
| OpenClinica | 4.2 ★ | 24 | 4.6 ★ | 37 |
| TrialKit | 4.5 ★ | 27 | 4.5 ★ | 36 |
| ClinCapture | 4.0 ★ | 1 | 4.9 ★ | 21 |
Snapshot of publicly listed ratings captured in 2026; some values were not available at capture time. Ratings and counts change continually, so confirm current figures on G2 and Capterra. On Capterra, reviewers also score platforms on ease of use, functionality, value for money, and customer service, which are worth reading directly for your priorities.
A fair reading: Clinion is among the higher-rated platforms in this snapshot, although several competitors have substantially larger review volumes. Weigh both the score and the sample size for your shortlist.
— Find your shortlist
Which EDC fits your organization and study type?
No single platform is the right fit for every organization. The right shortlist depends on who you are and what you run. Each group lists commonly relevant options from this comparison, not endorsements, weighted toward the platforms compared on this page.
Emerging & mid-size CROs
Clinion, ClinCapture, TrialKit, Castor. Prioritize fast builds, connected modules, and multi-study economics.
Biotech (clinical-stage)
Clinion, Medrio, Viedoc. Speed to first patient and lean, no-code setup matter most.
Medical device / MDR
Castor, Clinion, Medidata Rave Lite. Look for PMCF and long-term follow-up support.
Academic research
OpenClinica, Viedoc, Clinion. Cost, ease of use, and investigator-initiated trial support are key.
Large / global pharma
Medidata Rave, Veeva Vault. Enterprise scale, deep submission history, and existing infrastructure win here.
Decentralised & hybrid trials
Clinion, Castor, TrialKit. Remote capture, eConsent, ePRO, and mobile are essential.
Prioritize fast builds, connected modules, and multi-study economics.
Speed to first patient and lean, no-code setup matter most.
Look for PMCF and long-term follow-up support.
Cost, ease of use, and investigator-initiated trial support are key.
Enterprise scale, deep submission history, and existing infrastructure win here.
Remote capture, eConsent, ePRO, and mobile are essential.
— Decision framework
How do you choose the right EDC platform?
Seven steps that separate the right platform from the longest feature list. The prompts in each are what to actually ask or test, not just what to read on a datasheet.
Start with your organization, not the feature list
An emerging biotech running one or two studies has different needs from a global CRO managing dozens of sponsors.
Weigh: speed and cost predictability (biotech), multi-study scalability and sponsor flexibility (CRO), device workflows and long-term follow-up (MedTech), scale and standardization (large pharma).
Evaluate the study-build operating model
The real question is who actually builds and maintains the study.
Compare: vendor-dependent vs certified-specialist-dependent vs self-service no-code vs AI-assisted. This matters more than a binary ‘study builder: yes’.
Test a real protocol amendment
Do not evaluate only the initial demo. Amendments are where platforms diverge.
Ask each vendor to: add a visit, change a field, modify an edit check, publish it while the study is live, and show what happens to existing data.
Compare data review, not just data capture
Modern evaluation extends well beyond entering data.
Check whether reviewers can: find discrepancies, manage queries, review across subjects and forms, run SDV and remote SDV, review audit trails, access external data, generate listings, and move directly from a finding to action.
Understand what ‘AI-powered’ actually means
Require a demonstration of a production workflow, not a slide.
Ask: what task the AI performs, what inputs it uses, whether users can approve or reject output, whether it is traceable, whether it runs on live data, and how it is validated.
Evaluate native integration vs connected products
‘Do you have RTSM?’ is a starting question.
Ask: is it native or a separate product, is there one login, how does subject data synchronise, which system owns the data, and is reconciliation required? Repeat for ePRO/eCOA, eConsent, CTMS, eSource, and eTMF.
Look beyond license price
Total cost of ownership is more than the headline.
Include: licenses, study builds, programming, integrations, validation, training, amendments, reporting, professional services, support, and additional modules.
An emerging biotech running one or two studies has different needs from a global CRO managing dozens of sponsors.
Weigh: speed and cost predictability (biotech), multi-study scalability and sponsor flexibility (CRO), device workflows and long-term follow-up (MedTech), scale and standardization (large pharma).
The real question is who actually builds and maintains the study.
Compare: vendor-dependent vs certified-specialist-dependent vs self-service no-code vs AI-assisted. This matters more than a binary ‘study builder: yes’.
Do not evaluate only the initial demo. Amendments are where platforms diverge.
Ask each vendor to: add a visit, change a field, modify an edit check, publish it while the study is live, and show what happens to existing data.
Modern evaluation extends well beyond entering data.
Check whether reviewers can: find discrepancies, manage queries, review across subjects and forms, run SDV and remote SDV, review audit trails, access external data, generate listings, and move directly from a finding to action.
Require a demonstration of a production workflow, not a slide.
Ask: what task the AI performs, what inputs it uses, whether users can approve or reject output, whether it is traceable, whether it runs on live data, and how it is validated.
‘Do you have RTSM?’ is a starting question.
Ask: is it native or a separate product, is there one login, how does subject data synchronise, which system owns the data, and is reconciliation required? Repeat for ePRO/eCOA, eConsent, CTMS, eSource, and eTMF.
Total cost of ownership is more than the headline.
Include: licenses, study builds, programming, integrations, validation, training, amendments, reporting, professional services, support, and additional modules.
Key Takeaways: Clinion vs Leading EDC Platforms
Enterprise vs mid-market:
Medidata and Veeva lead on scale and submission history; Clinion, Viedoc, Castor, Medrio, ClinCapture, and TrialKit lead on speed, unified modules, and predictable cost. Rave Lite is Medidata’s move into the smaller-study segment.
AI is the 2026 dividing line:
Clinion, Medidata, TrialKit, and ClinCapture publicly offer AI; Clinion is distinctive for AI spanning the clinical data lifecycle, including Agentic Assistant, a multi-agent conversational AI.
Evaluate AI by what it does:
demand a production workflow and ask about inputs, approval, traceability, live data, and validation.
Read reviews with volume in mind:
Clinion is among the higher-rated platforms here, while several competitors carry substantially larger review bases.
Shortlist by fit: match the platform to your organization, study phase, and how much you value AI-assisted capabilities, not to the longest feature list.
Enterprise vs mid-market: Medidata and Veeva lead on scale and submission history; Clinion, Viedoc, Castor, Medrio, ClinCapture, and TrialKit lead on speed, unified modules, and predictable cost. Rave Lite is Medidata’s move into the smaller-study segment.
AI is the 2026 dividing line: Clinion, Medidata, TrialKit, and ClinCapture publicly offer AI; Clinion is distinctive for AI spanning the clinical data lifecycle, including Agentic Assistant, a multi-agent conversational AI.
Evaluate AI by what it does: demand a production workflow and ask about inputs, approval, traceability, live data, and validation.
Read reviews with volume in mind: Clinion is among the higher-rated platforms here, while several competitors carry substantially larger review bases.
Shortlist by fit: match the platform to your organization, study phase, and how much you value AI-assisted capabilities, not to the longest feature list.
— Where Clinion fits
Where does Clinion EDC fit in the market?
Clinion is designed for emerging and mid-size CROs, biotech, MedTech, and pharmaceutical organizations that want configurable EDC combined with AI-assisted clinical data workflows on one connected eClinical modules on one platform.
AI across the clinical data lifecycle
An AI study builder, AI CDASH mapping, source-to-CRF, AI medical coding, a DICOM image repository with automatic PHI de-identification, audit-trail review, and Agentic Assistant for conversational protocol, operations, and clinical-data querying.
Study changes without disruption
Configure and manage post-production changes while maintaining version control and data continuity, without planned downtime.
A connected eClinical environment
EDC linked natively with RTSM, ePRO, eConsent, eSource, CTMS, and eTMF, reducing reconciliation and integration overhead.
Human-controlled AI
AI assists clinical and data-management teams while review, approval, and query actions stay controlled by authorised users.
— Transparency
How We Compared EDC Platforms Across Key Buying Criteria
This comparison draws on publicly available vendor documentation, vendor websites, and third-party software review platforms including G2 and Capterra, as of the review date. Vendor functionality, packaging, and pricing change over time, and Clinion has not independently validated every third-party vendor claim. Organizations should confirm requirements directly with each vendor during their evaluation or RFP process. Where a capability was unclear or not publicly documented, it is marked accordingly rather than assumed.
Last reviewed: September 2026.
— See it in your context
Compare EDC platforms, then see Clinion in your own study
Choosing the right EDC platform goes beyond comparing features. It is about finding a solution that aligns with your study protocol, clinical workflows, operational requirements, and budget.
Discover how Clinion AI can simplify and accelerate your clinical trials through rapid study build, seamless mid-study changes/amendments, efficient data review, and AI-assisted reporting.
Experience Clinion AI with a personalised demonstration tailored to your study requirements and explore how our integrated eClinical platform can improve efficiency, streamline operations, and support data-driven decision-making throughout the clinical trial lifecycle.
Why Your EDC Needs an AI-Enabled Upgrade
Learn how to assess legacy EDC limitations, plan data migration, maintain validation, protect study continuity, and manage the transition to a modern EDC platform.
— FAQS
Frequently Asked Questions (FAQ)
There is no single EDC that is best for every trial. Large global sponsors tend to prioritize enterprise scale and established global infrastructure (Medidata Rave, Veeva Vault), while emerging and mid-size CROs, biotech, and medical device teams tend to prioritize study-build speed, AI-assisted capabilities, integrated modules, usability, and predictable cost (Clinion, Medrio, Viedoc, Castor, TrialKit, ClinCapture). OpenClinica adds a modular option with open-source heritage. Match the platform to your organization, study phase, and how much you value AI-assisted capabilities.
EDC is the electronic collection of clinical trial data through electronic case report forms. CDMS is the broader workflow around that data, from capture through cleaning, querying, and database lock. Modern platforms such as Clinion, Medidata, Veeva, and Castor offer EDC as one module inside a unified data management suite.
AI within a platform can support tasks ranging from study build, CDASH mapping to coding, discrepancy detection, source-data extraction, reporting, and conversational access to study data. The capabilities vary significantly across platforms. Clinion integrates AI across multiple stages of the clinical data lifecycle including Agentic Assistant, a multi-agent conversational assistant designed to support study-related workflows and data interactions; Medidata focuses AI on configuration and analytics; Castor focuses on source-data extraction. Veeva Vault EDC and OpenClinica do not currently emphasise built-in AI.
EDC study-build timelines vary by protocol complexity, library reuse, integrations, validation requirements, amendment strategy, and the vendor operating model. Cloud, no-code platforms with template (libraries) driven approach typically build straightforward studies in roughly two to eight weeks. Clinion AI accelerates study setup through its standardized, CDASH-aligned Global Library, enabling efficient CRF configuration and streamlined deployment, with an average go-live of around four weeks for typical studies. Enterprise, consultant-led platforms such as Medidata and Veeva often take three to six months. Solutions such as Medidata Rave Lite may offer shorter deployment timelines for selected study types particularly for repeat studies.
Medidata Rave remains one of the most established and widely adopted EDC platforms particularly among large pharma and global CROs.
However, the EDC landscape has evolved significantly, with modern cloud-based platforms offering competitive functionality, faster study builds, flexible configurations, AI-driven automation, and cost-effective deployment models.
Clinion AI, Viedoc, Castor, and Medrio provide alternatives for organisations seeking greater flexibility and operational efficiency. Clinion AI further differentiates itself through integrated AI capabilities supporting study setup, CDASH mapping, medical coding, data review, and reporting.
Pricing models differ more than headline prices. Enterprise platforms (Medidata, Veeva) use custom, often multi-year contracts, with Rave Lite offering a tailored model for smaller studies. Cloud platforms use per-study or subscription pricing; Viedoc publishes its pricing model (contact sales for pricing), OpenClinica offers a free community edition, and Clinion uses study-scoped pricing. Because most vendors quote by study size, compare total cost of ownership, not just licence price.
Multi-study scalability, rapid and repeatable configuration, flexibility for varied sponsor requirements, strong reporting, native integrations across modules, dependable support, and predictable per-study or subscription economics. Clinion, ClinCapture, TrialKit, and Castor are common CRO choices.
Speed to first patient, low internal resource requirements, no-code configuration, protocol flexibility for amendments, integrated modules, and the ability to scale with the pipeline. Clinion, Medrio, and Viedoc are frequent choices.
Support for device-study designs, long-term and post-market follow-up (including EU MDR PMCF), ePRO/eCOA and eConsent, robust auditability, and regulatory fit. Castor and Clinion are commonly considered, and Medidata offers Rave Lite for device feasibility and post-market studies.
Integrated platforms reduce reconciliation, simplify the audit trail, and cut vendor overhead, which suits lean and mid-size teams. Point solutions can offer deeper specialization but add integration work. When comparing, check whether modules such as RTSM, ePRO/eCOA, and eConsent are native or separate products, whether there is one login, and which system owns the data.
Still have questions?
Explore how Clinion AI can accelerate your trial – reach out to our team.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%